Summary The expression of urokinase-type plasminogen activator (uPA) was investigated in squamous cell carcinoma of the human larynx. For this purpose, tissue extracts from 25 matched samples of normal mucosa and neoplastic larynx were compared for the levels of uPA activity as evaluated by a chromogenic PA assay and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS -PAGE) zymography. Also, uPA antigen was quantified by enzyme-linked immunosorbent assay (ELISA) in 19 cases. The results demonstrate a significant increase in the levels of uPA activity and protein in tumour tissue extracts, more pronounced in tumours with lymph node metastases. Immunohistochemistry performed on 70 biopsies showed that uPA positivity is present both in neoplastic cells and in fibroblast-like cells and macrophages. However, depending on the histological grading and invasive capacity of the tumour, a pronounced intra-and intertumoral heterogeneity in uPA staining was observed. In situ hybridisation confirmed the presence of uPA mRNA in both tumour and stromal cells. The present study provides experimental evidence for a role of uPA in the invasive growth of human laryngeal carcinoma.
Degradation of the extracellular matrix and other tissue barriers by proteases is a prerequisite for neoplastic growth and metastasis (Mignatti and Rifkin, 1993) . Plasminogen activators (PAs) are serine-proteases which convert plasminogen to plasmin and regulate intravascular fibrinolysis and extracellular proteolysis. There are two types of PAs, tissuetype PA (tPA) and urokinase-type PA (uPA), which differ in molecular weight, immunological reactivity, enzymatic properties and genomic sequence (Dan0 et al., 1985) .
uPA is considered to play an important role in different processes where extracellular proteolysis is required, including cell migration, tissue remodelling during development, angiogenesis and invasive growth in normal and pathological conditions. In particular, several malignant tumours, e.g. carcinoma of the colon (Kohga et al., 1985; De Bruin et al., 1987a, b; Sim et al., 1988; Nishino et al., 1988; Pyke et al., 1991) , lung Sappino et al., 1987) , breast , uterus (Whitney et al., 1985; Sugimira et al., 1992) , urinary bladder (Hasui et al., 1989; 1992) and skin (Sappino et al., 1991) , express high levels of uPA compared with normal tissue. Numerous findings indicate that uPA is involved in tissue degradation during invasive growth by promoting breakdown of extracellular matrix proteins either by a direct action of plasmin or through a plasmin-mediated activation of latent collagenase (Ossowski et al., 1983 (Ossowski et al., , 1988 Mignatti et al., 1986; Saksela and Rifkin, 1988) .
Previous observations had demonstrated a role for uPA in the in vitro invasive capacity of cell lines isolated from human squamous carcinoma of the oral cavity (Clayman et al., 1993) . Also, the determination of uPA antigen performed in the same study on a limited set of patients suggested a possible up-regulation of uPA expression in human laryngeal carcinomas in situ. On this basis, we decided to investigate more extensively the expression of uPA in the carcinoma of human larynx. In the present study, matched samples of normal mucosa and neoplastic laryngeal tissue were compared for levels of uPA activity and antigen, uPA localisation by immunohistochemistry, and uPA mRNA expression by in situ hybridisation. The findings demonstrate a significant increase in the levels of uPA activity and protein in the extracts of human laryngeal carcinoma, the extent of uPA up-regulation being related to the metastatic potential of the tumour. Accumulation of uPA antigen and mRNA was observed both in neoplastic and stromal cells. Our data point to a role for uPA in the invasive growth of human laryngeal carcinoma.
Materials and methods

Laryngeal biopsies
Matched samples of normal mucosa and neoplastic laryngeal tissue were obtained from 70 patients who underwent total (n = 32) or supraglottic (n = 38) laryngectomy for laryngeal carcinoma. The normal mucosa sample was taken at least 3 cm from the neoplastic lesion. Samples showing large areas of necrosis were excluded from the study. Tissues were collected immediately after surgical removal and divided in two parts: one part was frozen at -70°C for the determination of uPA activity and antigen; the other one was fixed in 4% (w/v) paraformaldehyde for immunohistochemical studies and for in situ hybridisation. The histological diagnosis, performed on traditionally haematoxylin-eosin stained sections, identified the tumours as G1 (n = 15), G2 (n = 30) and G3 (n = 25) squamous cell carcinomas according to the International Union Against Cancer-modified Broders' system and confirmed the absence of lesions in normal mucosa samples. Lymph node metastases were present in 30 cases. All 70 matched normal and tumour biopsies were examined for uPA immunostaining. Twentyfive GI, G2 and G3 matched samples (11 from metastatic tumours and 14 from non-metastatic tumours) were also examined for uPA levels by enzymatic activity assay and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) zymography. Nineteen out of the 25 samples were evaluated also by uPA enzyme-linked immunosorbent assay (ELISA) (7 from metastatic tumours and 12 from nonmetastatic tumours). Finally, eight matched biopsies were analysed by in situ hybridisation. SDS-PAGE zymography and uPA ELISA For determination of the molecular weight of the PA activity in normal and neoplastic larynx, tissue extracts (700 Mug of total protein) were run on SDS-10% polyacrylamide gel under non-reducing conditions. Then, proteins were electrophoretically transferred from the gel to a nitrocellulose membrane for 2 h at 400 mA in 40 mm sodium phosphate buffer, pH 6.5. Zymography of the proteins transferred to the membrane was carried out on a casein -agarose gel as described (Colombi et al., 1986) . Control gels were made in the absence of plasminogen to identify plasminogenindependent caseinolytic activities.
To evaluate the levels of uPA antigen, 50 Mg of the tissue extracts were analysed by the IMUBIND uPA ELISA kit (American Diagnostica) according to manufacturer's instructions.
Immunohistochemistry
Specimens were fixed with 4% paraformaldehyde for 2 h at 4°C and cryoprotected through 5 h intervals of graded sucrose concentrations (5-30%) in phosphate-buffered saline (PBS). After embedding in OCT compound, samples were frozen, cut at 4 gm thickness using a freeze-microtome, and mounted on chrome-alum-gelatin-coated glass slides. After three rinses in 1% Triton X-100/PBS, sections were incubated for 30 min with 0.3% hydrogen peroxide in methanol to quench endogenous peroxidase activity. Slides were then washed three times for 10 min each in 1% Triton X-l00/PBS, followed by a 30 min incubation at room temperature with 20% normal rabbit serum (Dakopatts, Denmark) in PBS to reduce non-specific background staining. After two rinses in PBS, sections were incubated overnight at 4°C with goat polyclonal anti-human uPA antibody (60 Mg ml-1 in PBS; Biopool, Sweden) or goat polyclonal anti-human tPA (12 Mg ml-1; Biopool), followed by 1 h incubation at room temperature. Sections were washed with PBS and incubated for 45 min with biotinylated rabbit anti-goat IgG (1:300) at room temperature. Formation of the antigen -antibody complexes was demonstrated with avidin -biotin -peroxidase complex (Dakopatts, Denmark), and bound peroxidase was developed with 3-amino-9-ethylcarbazole (Sigma) in acetate buffer, pH 5.2, added with hydrogen peroxide. The slides were lightly counterstained with haematoxylin and mounted.
The specificity of immunostaining was verified by: (1) omission of the first, second or third layer of antiserum; (2) substitution ofthe primary antibody with non-immune IgG; and (3) absorption of the primary antibody with highly purified antigen coupled to Sepharose beads. The results obtained with the polyclonal anti-uPA antibody were confirmed in 20 cases by staining of adjacent sections with a monoclonal anti-uPA antibody (Ab no. 3689, American Diagnostica).
In situ hybridisation The probe used was a 1.3 kb SmaI/BamHI fragment obtained from the pcUK176 recombinant plasmid harbouring the human uPA cDNA (provided by P Mignatti, University of Pavia). The probe (500 ng) was labelled to a specific activity of 1.5 x 107 c.p.m. jg-' by using the random primed DNA labelling method according to supplier's instructions (Molecular Biology, Boehringer Mannheim) in the presence of 6 gM [3H] dATP (92 Ci mM-1) (Amersham, Buckinghamshire, UK) and 6 gM each of unlabelled dCTP, dGTP and dTTP. The probe was separated from unincorporated nucleotides by precipitation with ethanol, dried and dissolved in the hybridisation buffer.
Routinely processed, paraformaldehyde-fixed sections were subjected to in situ hybridisation according to Moro et al. (1992) . Briefly, slides were sequentially immersed twice in PBS for 10 min, once in 1 Mg ml-' proteinase K dissolved in 2 mM calcium chloride/10 mM Tris-HCl, pH 7.4, for 8 min at 37°C, and twice in 2 Mg ml-' glycine in PBS for 3 min.
Sections were then acetylated in freshly prepared 0.25% acetic anhydride in 0.1 M triethanolamine-HCl, pH 8.0, for 10 min (Hayashi et al., 1978) . Finally the slides were washed twice in PBS for 3 min, dehydrated in 50%, 75%, 95% and 100% ethanol, 5 min for each passage, and air-dried. The hybridisation was performed in a mixture containing 1 Mg ml-1 3H-labelled probe prepared according to Moro et al. (1992) , heated at 70°C for 10 min and cooled in ice.
Aliquots (30 Ml) were applied onto each section and incubated at 42°C for [16] [17] [18] h. Slides were rinsed four times in 50% formamide/ 2 x SSC for 15 min at 39°C and twice in 1 x SSC for 30 min at room temperature. Autoradiography was performed by dipping the slides into Kodak NTB2 emulsion, air-drying for 2 h in the dark, and storing for 4 weeks in 'sealed boxes at 4°C. Slides were developed in Kodak D19 developer, fixed in Kodak fixer, rinsed in water, air-dried, stained with haematoxylin -eosin and mounted with glycerol-gelatin. For each specimen, controls included incubation with pBR322-labelled probe or with hybridisation mix only.
Image anslysis
The Magiscan image analysis system (Joyce Loebl, Gateshead, UK) was used to perform semi-quantitative evaluation of the hybridisation signals, according to Moro et al. (1992) . Briefly, the section image was input via a TV camera mounted on a Nikon light microscope, digitalised on the high resolution monitor and stored within the Magiscan's image memory. Five fields were chosen at random and analysed per slide. The ratio between the integrated density values of the area of the hybridisation grains and of the selected surface was determined for each field and nonspecific hybridisation signals were subtracted from all values. This procedure has been used previously to quantify gene expression both in cultured cells and in histological sections (Moro et al., 1990 (Moro et al., , 1992 Colombi et al., 1991 Colombi et al., , 1993 In agreement with the chromogenic PA activity assay, SDS-PAGE zymography confirmed that uPA activity was significantly higher in tumoral than in matched normal tissue extracts for all the patients examined and that the diagnosis of positive lymph node involvement was characterised by the highest levels of uPA activity (Figure 2 ). To assess whether the increased levels of uPA activity detected in tumour samples reflected an increase in uPA antigen content, an ELISA was used on 19 out of the 25 matched biopsies analysed above. As shown in Figure lb (Figure 3a -d) . In detail, we observed that in 12 out of the 15 Gl tumours examined most of the cellular nests were positive for uPA staining (Figure 3a) , while in remaining Gl tumours and in all G2 tumours examined cellular nests characterised by a strong uPA staining and areas completely devoid of uPA immunoreactivity were present within the same biopsy (Figure 3b) . Interestingly, in these cases the most intense reaction was usually detectable in tumour cells that appeared to. be well differentiated according to histological criteria, whereas positivity decreased in poorly differentiated cells (Figure 3b ). IN G3 tumours, uPA positivity was mainly localised in areas with invasive growth and degradation of surrounding tissue (Figure 3c ). Despite this heterogeneity. a general feature of the larynx tumours examined was that primary tumours with lymph node involvement were characterised by a more intense uPA staining in the cytoplasm of tumour cells than that observed in nonmetastatic tumours. Also. stromal fibroblast-like cells and macrophages showed uPA positivity in all tumours independently of the histological grading and lymph node involvement (Figure 3d ).
--,. -av +-. uPA up-regulation in laryngeal carcinoma S Parolini et al When samples were analysed for tPA immunoreactivity, positivity was limited to capillary endothelial cells in both normal and malignant tissue. No tPA staining was located in neoplastic cells (data not shown).
uPA mRNA expression in laryngeal cancer using in situ hybridisation To identify the cell types responsible for uPA production in laryngeal carcinoma, in situ hybridisation with a specific human uPA probe was performed in eight cases of normal larynx and corresponding laryngeal carcinoma of different histological grading. In all cases examined, neoplastic cells expressed uPA mRNA (Figure 4) Rijken and Collen, 1981; Neuman et al., 1989) .
It was demonstrated in the early 1970s that the transformation of cultured cells by oncogenic viruses caused a significant increase in the production of uPA (Ossowski et al., 1973; Goldberg, 1974; Unkeless et al., 1974) . Since then, several observations in vitro and in vivo have linked the expression of uPA to the transformed state. For instance, tumour tissue extracts from carcinomas of the colon, breast, lung and bladder all contained more uPA antigen and/or activity than did their normal counterparts Corasanti et al., 1980; Camiolo et al., 1981 Camiolo et al., , 1984 . Interestingly, different immunohistochemical studies have shown that uPA is localised in invading areas of the tumour, supporting the hypothesis of a role for uPA in tumour cell invasion (Skriver et al., 1984; Kohga et al., 1985; Kristensen et al., 1990) . Indeed, neutralising anti-uPA antibodies have been demonstrated to inhibit tumour cell invasion in different experimental models in vitro and in vivo (Ossowski and Reich, 1983; Hearing et al., 1988 In conclusion, the present study provides experimental evidence for a role of uPA in the invasive growth of squamous cell laryngeal carcinoma. The determination of uPA antigen in breast cancer tissue extracts has been shown to represent a significant prognostic factor for disease-free interval and total survival (Janicke et al., 1990 (Janicke et al., , 1992 Schmitt et al., 1990; Gr0ndahl-Hansen et al., 1993) . Further studies are required to assess whether uPA up-regulation also represents a useful prognostic factor for laryngeal carcinoma.
